0,965  0,001  Antimutagenic
0,944  0,004  Cyclophilin D inhibitor
0,944  0,004  Antidiabetic
0,941  0,002  NOS2 expression inhibitor
0,935  0,003  Mutagenic
0,918  0,003  Genotoxic
0,917  0,002  UGT1A9 substrate
0,902  0,003  Cytostatic
0,899  0,003  Hypoglycemic
0,891  0,003  Caspase 9 stimulant
0,888  0,003  Chemopreventive
0,887  0,004  Antioxidant
0,878  0,004  Radioprotector
0,874  0,004  Chemoprotective
0,876  0,009  Alpha-glucosidase inhibitor
0,863  0,003  Cardioprotectant
0,839  0,002  UGT1A1 substrate
0,822  0,003  Monophenol monooxygenase inhibitor
0,815  0,002  Melanin inhibitor
0,826  0,014  Apoptosis agonist
0,810  0,004  Free radical scavenger
0,808  0,004  AR expression inhibitor
0,809  0,006  Carcinogenic
0,806  0,004  Vasodilator, coronary
0,800  0,013  Transcription factor NF kappa B inhibitor
0,760  0,005  Antidiabetic (type 2)
0,754  0,003  Antihypotensive
0,753  0,003  Amylase inhibitor
0,743  0,004  Histamine release inhibitor
0,739  0,008  Antihypercholesterolemic
0,751  0,022  Antiinflammatory
0,721  0,005  Proliferative diseases treatment
0,706  0,005  Angiogenesis stimulant
0,704  0,013  Antileukemic
0,698  0,006  NOS3 expression inhibitor
0,695  0,005  UDP-glucuronosyltransferase substrate
0,690  0,005  Hepatic disorders treatment
0,677  0,005  DNA damaging
0,678  0,007  Antiparasitic
0,676  0,005  Antipyretic
0,661  0,005  Apoptosis antagonist
0,659  0,005  Amyloid beta aggregation inhibitor
0,657  0,004  Hepatoprotectant
0,661  0,012  Antibacterial
0,652  0,004  Antihypertriglyceridemic
0,651  0,005  Antihelmintic
0,666  0,019  Teratogen
0,650  0,005  Antiamyloidogenic
0,649  0,004  NOS3 expression enhancer
0,649  0,008  Nitric oxide antagonist
0,646  0,004  Skin whitener
0,642  0,002  AMP-activated protein kinase stimulant
0,649  0,010  CTGF expression inhibitor
0,623  0,005  Antihypoxic
0,621  0,010  Cytotoxic
0,608  0,007  Hypoxia-inducible factor 1 alpha inhibitor
0,604  0,004  Sulfotransferase substrate
0,603  0,004  Aldehyde dehydrogenase inhibitor
0,601  0,003  Xanthine oxidase inhibitor
0,616  0,023  TNF expression inhibitor
0,612  0,022  Embryotoxic
0,598  0,009  UGT1A6 substrate
0,597  0,021  CYP2C9 substrate
0,583  0,010  CYP2C19 inhibitor
0,578  0,006  RNA-directed DNA polymerase inhibitor
0,578  0,008  Antineoplastic (osteosarcoma)
0,573  0,004  Antidiabetic (type 1)
0,565  0,003  Antihemorrhagic
0,563  0,005  UGT1A3 substrate
0,567  0,012  Antineoplastic (brain cancer)
0,556  0,003  Carbonic anhydrase III inhibitor
0,577  0,025  Antineoplastic (colorectal cancer)
0,558  0,008  Vascular (periferal) disease treatment
0,565  0,017  Stroke treatment
0,573  0,031  CYP3A4 substrate
0,543  0,004  UGT2B1 substrate
0,561  0,036  Antineoplastic (lung cancer)
0,526  0,005  Insulin secretagoues
0,563  0,041  Antineoplastic (breast cancer)
0,537  0,019  Antineoplastic (cervical cancer)
0,518  0,005  Interferon gamma antagonist
0,517  0,010  Antineoplastic (lymphoma)
0,533  0,029  Antineoplastic (colon cancer)
0,527  0,025  Antipruritic, allergic
0,506  0,005  Platelet adhesion inhibitor
0,510  0,010  Antidiabetic symptomatic
0,515  0,018  Caspase 3 stimulant
0,497  0,007  Topoisomerase II inhibitor
0,494  0,005  Alkylator
0,515  0,027  Respiratory analeptic
0,499  0,012  ICAM1 expression inhibitor
0,507  0,023  Antineoplastic (melanoma)
0,497  0,014  DNA synthesis inhibitor
0,484  0,003  UDP-glucose 4-epimerase inhibitor
0,500  0,022  Antifungal
0,500  0,024  CYP1A2 substrate
0,480  0,005  Glutathione S-transferase substrate
0,494  0,023  Sensitization
0,474  0,003  Carbonic anhydrase XIII inhibitor
0,485  0,021  Antineoplastic (glioma)
0,469  0,005  Antidote
0,477  0,015  UGT2B4 substrate
0,490  0,034  Aldehyde oxidase inhibitor
0,457  0,005  UGT2B15 substrate
0,463  0,013  Antineoplastic (liver cancer)
0,481  0,032  Antithrombotic
0,483  0,035  Prostate cancer treatment
0,497  0,050  Alzheimer's disease treatment
0,450  0,003  Antiviral (Influenza B)
0,476  0,031  CYP2C19 substrate
0,452  0,010  Antiviral (Herpes)
0,471  0,033  Immunostimulant
0,443  0,007  Antiviral (Influenza)
0,436  0,006  Protein kinase stimulant
0,451  0,023  Antiprotozoal (Leishmania)
0,438  0,018  Vasodilator
0,424  0,008  Lipid peroxidase inhibitor
0,420  0,005  Interleukin 4 antagonist
0,445  0,035  Antineoplastic (ovarian cancer)
0,437  0,030  Antineoplastic (pancreatic cancer)
0,452  0,046  Immunosuppressant
0,409  0,005  Cystathionine beta-synthase inhibitor
0,440  0,039  Bone diseases treatment
0,421  0,024  Antineoplastic (glioblastoma multiforme)
0,401  0,005  Topoisomerase I inhibitor
0,403  0,008  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,423  0,032  Antiosteoporotic
0,395  0,007  Antiviral (Influenza A)
0,415  0,030  Antineoplastic (non-small cell lung cancer)
0,401  0,028  Radiosensitizer
0,383  0,012  DNA methylase inhibitor
0,375  0,005  Aldose reductase substrate
0,373  0,005  SULT1A3 substrate
0,372  0,005  Topoisomerase II alpha inhibitor
0,385  0,018  Antineoplastic (sarcoma)
0,402  0,037  Analeptic
0,369  0,005  Expectorant
0,366  0,004  Uric acid excretion stimulant
0,366  0,006  NADPH oxidase inhibitor
0,368  0,009  Diabetic nephropathy treatment
0,372  0,012  Antialcoholic
0,398  0,039  Lipoprotein disorders treatment
0,364  0,006  Antineoplastic antibiotic
0,397  0,041  Spasmolytic
0,386  0,032  Interleukin 2 agonist
0,359  0,005  Carbonic anhydrase VI inhibitor
0,368  0,013  Antipruritic, non-allergic
0,352  0,014  DNA methyltransferase I inhibitor
0,343  0,006  Antiprotozoal (Coccidial)
0,363  0,026  Peroxidase inhibitor
0,346  0,015  Antiviral (Hepatitis)
0,373  0,043  Metabolic disease treatment
0,359  0,030  Antineoplastic (small cell lung cancer)
0,346  0,018  UGT2B7 substrate
0,341  0,013  Alpha-N-acetylglucosaminidase inhibitor
0,391  0,063  Ulceration
0,338  0,016  Carcinogenic, group 3
0,336  0,014  Protein-tyrosine phosphatase inhibitor
0,357  0,036  Tumour necrosis factor alpha release inhibitor
0,353  0,035  Antineoplastic (renal cancer)
0,345  0,028  Antineoplastic enhancer
0,328  0,011  Insulin sensitizer
0,321  0,004  DNA repair enzyme inhibitor
0,325  0,008  Antitussive
0,343  0,027  Cyclic AMP phosphodiesterase inhibitor
0,333  0,018  VCAM1 expression inhibitor
0,334  0,023  P-glycoprotein inhibitor
0,342  0,037  Myocardial infarction treatment
0,362  0,060  Cholesterol antagonist
0,357  0,057  Immunomodulator
0,308  0,011  DNA polymerase I inhibitor
0,401  0,104  Antineoplastic (solid tumors)
0,312  0,016  Antineoplastic (gastric cancer)
0,304  0,010  Nitric-oxide synthase stimulant
0,299  0,005  Selectin antagonist
0,321  0,034  Antineoplastic (bladder cancer)
0,292  0,007  Histidine decarboxylase inhibitor
0,295  0,011  Protein-tyrosine phosphatase 1B inhibitor
0,289  0,008  Mediator release inhibitor
0,293  0,013  Alkaline phosphatase inhibitor
0,311  0,040  Antineoplastic (lymphocytic leukemia)
0,282  0,012  Antifungal enhancer
0,273  0,005  Aldose reductase inhibitor
0,275  0,007  Beta glucuronidase inhibitor
0,294  0,027  Peptidyltransferase inhibitor
0,268  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,277  0,016  Adenylate cyclase inhibitor
0,283  0,024  Antineoplastic (squamous cell carcinoma)
0,265  0,006  Alcohol dehydrogenase inhibitor
0,299  0,048  GST M1-1 substrate
0,254  0,005  Creatine kinase inhibitor
0,279  0,034  UGT1A4 substrate
0,249  0,008  NADH dehydrogenase inhibitor
0,243  0,005  Carcinogenic, group 2A
0,331  0,093  CYP2C9 inhibitor
0,250  0,016  DNA intercalator
0,242  0,010  Cyclooxygenase 3 inhibitor
0,260  0,028  Antihelmintic (Nematodes)
0,241  0,010  Telomerase inhibitor
0,252  0,022  Antiviral (Hepatitis C)
0,307  0,078  CYP2D6 substrate
0,240  0,018  Antineoplastic antimetabolite
0,254  0,036  Neurotrophic factor enhancer
0,220  0,007  Papain-like protease (SARS coronavirus) inhibitor
0,274  0,063  Interleukin agonist
0,226  0,017  Carcinogenic, group 2B
0,226  0,019  Mannose-6-phosphate isomerase inhibitor
0,228  0,024  Antiviral (Ebola)
0,223  0,020  Chelator
0,221  0,023  Antiviral (Hepatitis B)
0,209  0,012  Antibiotic
0,218  0,021  Gout treatment
0,219  0,023  Cholesterol synthesis inhibitor
0,268  0,072  Antiprotozoal (Trypanosoma)
0,208  0,017  Carbonic anhydrase XV inhibitor
0,286  0,096  Antineoplastic (endocrine cancer)
0,202  0,013  Mucolytic
0,199  0,011  Phosphofructokinase-1 inhibitor
0,197  0,010  HIV-1 integrase (3'-Processing) inhibitor
0,222  0,037  Antineoplastic (carcinoma)
0,194  0,012  Antineoplastic (uterine cancer)
0,197  0,015  Antineoplastic, alkylator
0,198  0,017  Beta amyloid protein antagonist
0,199  0,019  SULT1A1 substrate
0,208  0,031  Carcinogenic, group 1
0,178  0,002  Sodium/glucose cotransporter inhibitor
0,185  0,010  HIV-1 integrase (Strand Transfer) inhibitor
0,193  0,019  Antihelmintic (Trematoda)
0,202  0,029  Cell wall synthesis inhibitor
0,177  0,005  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,209  0,038  Phospholipase C inhibitor
0,205  0,036  Antineoplastic (bone cancer)
0,211  0,042  VEGF expression inhibitor
0,259  0,090  Antineoplastic (multiple myeloma)
0,184  0,017  Gastritis treatment
0,178  0,013  Heat shock protein 70 antagonist
0,176  0,011  Thioredoxin inhibitor
0,200  0,037  UGT2B10 substrate
0,173  0,015  Triose-phosphate isomerase inhibitor
0,227  0,070  Antiviral (HIV)
0,174  0,017  Multidrug resistance-associated protein 1 inhibitor
0,156  0,002  Sodium/glucose cotransporter 1 inhibitor
0,275  0,125  GST A substrate
0,177  0,028  Adenylate cyclase stimulant
0,201  0,054  Dual specificity phosphatase inhibitor
0,153  0,007  Antiviral (Dengue virus)
0,191  0,045  ATPase inhibitor
0,182  0,036  Psychosexual dysfunction treatment
0,238  0,093  5 Hydroxytryptamine uptake stimulant
0,239  0,094  5 Hydroxytryptamine release stimulant
0,158  0,013  SULT1E1 substrate
0,145  0,001  Sodium/glucose cotransporter 2 inhibitor
0,185  0,043  Antidiarrheal
0,193  0,053  Liver fibrosis treatment
0,169  0,030  Antiviral (Poxvirus)
0,159  0,020  Estrogen antagonist
0,224  0,085  Platelet antagonist
0,194  0,055  Thrombolytic
0,161  0,025  Photosensitizer
0,219  0,083  Hypolipemic
0,188  0,054  Antirickettsial
0,152  0,020  Toll-Like receptor 4 antagonist
0,139  0,008  Antibiotic Glycopeptide-like
0,173  0,043  CF transmembrane conductance regulator agonist
0,211  0,081  Antiulcerative
0,148  0,019  Aminoacyl-tRNA synthetase inhibitor
0,179  0,051  UGT2B9 substrate
0,133  0,008  Anticholelithogenic
0,190  0,066  Diabetic retinopathy treatment
0,210  0,086  Cardiodepressant
0,236  0,113  Antiischemic
0,263  0,141  Antineoplastic (non-Hodgkin's lymphoma)
0,265  0,143  Antiobesity
0,185  0,070  Dual specificity phosphatase 3 inhibitor
0,128  0,014  Postmenopausal disorders treatment
0,127  0,014  Thioredoxin reductase inhibitor
0,118  0,007  Fatty acid synthase inhibitor
0,123  0,015  Na+ K+ transporting ATPase inhibitor
0,241  0,134  Vasodilator, peripheral
0,150  0,043  Ca2+-transporting ATPase inhibitor
0,116  0,011  Phosphorylase inhibitor
0,166  0,061  Hexokinase inhibitor
0,117  0,012  Antidote, heavy metal
0,125  0,021  Glutamate dehydrogenase inhibitor
0,285  0,183  5 Hydroxytryptamine release inhibitor
0,128  0,028  UGT2B11 substrate
0,103  0,003  Cholesterol absorption inhibitor
0,147  0,049  Antibacterial (Helicobacter pylori)
0,108  0,010  Antimycoplasmal
0,125  0,027  Estrogen receptor beta antagonist
0,115  0,019  Interferon agonist
0,108  0,013  Neuraminidase inhibitor
0,139  0,044  Microtubule formation inhibitor
0,146  0,054  M18 aspartyl aminopeptidase inhibitor
0,129  0,037  Electron transport complex I inhibitor
0,106  0,015  Neuraminidase (influenza) inhibitor
0,122  0,031  Protein kinase C zeta inhibitor
0,105  0,014  Xanthine dehydrogenase inhibitor
0,111  0,021  Carbonic anhydrase VA inhibitor
0,162  0,073  Interleukin 6 antagonist
0,127  0,038  Dementia treatment
0,220  0,131  12-Lipoxygenase inhibitor
0,098  0,009  Carbonic anhydrase VII inhibitor
0,117  0,028  Phosphodiesterase 6D inhibitor
0,126  0,039  Chronic obstructive bronchitis treatment
0,093  0,005  Inosine monophosphate dehydrogenase inhibitor
0,115  0,027  Interleukin 5 antagonist
0,111  0,024  Carbonic anhydrase V inhibitor
0,103  0,016  Estrogen agonist
0,201  0,115  Antiviral (West Nile virus)
0,119  0,033  Actinic keratosis treatment
0,123  0,037  Vascular dementia treatment
0,252  0,170  Antineoplastic (myeloid leukemia)
0,135  0,053  Growth stimulant
0,114  0,034  Antispirochetal
0,149  0,069  Hemostatic
0,086  0,007  Glucose-6-phosphate isomerase inhibitor
0,133  0,057  Cell adhesion inhibitor
0,102  0,026  CDC25A inhibitor
0,083  0,010  Alpha-mannosidase inhibitor
0,155  0,083  Arachidonic acid antagonist
0,206  0,134  Lipoxygenase inhibitor
0,076  0,004  Protein 30S ribosomal subunit inhibitor
0,098  0,029  Histone deacetylase SIRT1 stimulant
0,098  0,029  Histone deacetylase stimulant
0,210  0,141  Antimycobacterial
0,091  0,023  Antitreponemal
0,117  0,049  DOPA decarboxylase inhibitor
0,138  0,071  Neurotrophic factor
0,077  0,010  Adenosine deaminase inhibitor
0,102  0,037  Transcription factor NF kappa B stimulant
0,084  0,019  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,160  0,095  Succinate dehydrogenase inhibitor
0,073  0,010  Mannosidase inhibitor
0,069  0,006  Antibiotic Aminoglycoside-like
0,094  0,032  Estrogen receptor alpha antagonist
0,093  0,031  Lipase inhibitor
0,114  0,052  Antiviral (SARS coronavirus)
0,114  0,052  Antiviral (Coronavirus)
0,154  0,092  Neurotensin receptor agonist
0,069  0,008  Arginase inhibitor
0,110  0,050  Sphingomyelinase inhibitor
0,070  0,010  Equilibrative nucleoside transport protein inhibitor
0,080  0,024  Interferon inducer
0,073  0,019  Carbonic anhydrase XIV inhibitor
0,111  0,057  MAO A inhibitor
0,105  0,051  Breast cancer-resistant protein inhibitor
0,097  0,044  ATPase (Vacuolar H+) inhibitor
0,087  0,033  HIV-1 integrase inhibitor
0,233  0,180  15-Lipoxygenase inhibitor
0,110  0,058  HDL-cholesterol increasing
0,157  0,107  Non-steroidal antiinflammatory agent
0,075  0,027  Nitric oxide donor
0,117  0,068  Constipation treatment
0,155  0,107  Septic shock treatment
0,165  0,118  Pneumotoxic
0,073  0,027  Protein kinase C eta inhibitor
0,059  0,013  Neuraminidase (Influenza A) inhibitor
0,104  0,061  5-Lipoxygenase inhibitor
0,099  0,055  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,120  0,078  Acetylcholinesterase inhibitor
0,058  0,018  Estrogen receptor beta agonist
0,048  0,010  Nucleoside transporters inhibitor
0,069  0,032  Purinergic P2X1 antagonist
0,235  0,198  Antiparkinsonian
0,101  0,065  Adenylate kinase inhibitor
0,058  0,023  Topoisomerase II beta inhibitor
0,116  0,082  Toll-Like receptor 2 antagonist
0,065  0,031  Carbonic anhydrase VB inhibitor
0,147  0,115  LDLR expression enhancer
0,130  0,099  Eye irritation, high
0,060  0,031  Protein 50S ribosomal subunit inhibitor
0,097  0,067  Anabolic
0,041  0,012  ATP citrate lysase inhibitor
0,091  0,063  Potassium channel (Ca-activated) activator
0,045  0,019  Estrogen receptor alpha agonist
0,100  0,073  Choleretic
0,033  0,007  Dopamine D1 agonist
0,115  0,090  Bone formation stimulant
0,033  0,008  Inosine monophosphate dehydrogenase 1 inhibitor
0,109  0,084  Transcription factor STAT6 inhibitor
0,054  0,031  Glucose-6-phosphate translocase inhibitor
0,062  0,040  Aromatase inhibitor
0,059  0,037  Lipocortins synthesis agonist
0,060  0,039  Adenosine A1 receptor antagonist
0,031  0,011  Adenosine A1 receptor agonist
0,040  0,020  Phosphoglycerate kinase inhibitor
0,036  0,016  Estrogen-related receptor beta antagonist
0,088  0,068  Antiviral (Hepatitis A)
0,067  0,048  Potassium channel large-conductance Ca-activated activator
0,024  0,005  Antibiotic Anthracycline-like
0,109  0,091  Cyclooxygenase 1 inhibitor
0,073  0,055  Phosphodiesterase VI inhibitor
0,060  0,043  Carbamoyl phosphate synthetase inhibitor
0,072  0,055  Adenosine A3 receptor antagonist
0,126  0,109  Acute respiratory distress syndrome (ARDS) treatment
0,042  0,027  Thymidine kinase inhibitor
0,021  0,007  Telomerase stimulant
0,052  0,038  Alpha tubulin antagonist
0,047  0,033  Microtubule stabilization
0,194  0,181  CYP3A4 inhibitor
0,027  0,014  Vanilloid 2 agonist
0,028  0,019  1,3-Beta-glucan synthase inhibitor
0,044  0,036  Antimetabolite
0,099  0,091  MAO inhibitor
0,053  0,046  Postcoital contraceptive
0,060  0,056  Transcription factor RelA inhibitor
0,030  0,027  Catechol O-methyltransferase inhibitor
0,011  0,007  Purinergic P2Y2 agonist
0,018  0,015  Inosine monophosphate dehydrogenase 2 inhibitor
0,014  0,011  Adenosine A2b receptor agonist
0,104  0,102  Alcohol dehydrogenase substrate
0,015  0,013  Antibiotic Tetracycline-like
0,016  0,015  Adenosine A3 receptor agonist
0,031  0,031  Tubulin agonist

